The total pharmaceutical market in France saw a steady increase in the volume of generics units from 2013 to 2023. The market's unit volume grew from 23.5 in 2013 to 33.5 in 2023, marking a CAGR of 2.3% over the last five years. Year-on-year variations indicate a mix of robustness and volatility, where 2023 saw an increase of 2.76% from the previous year.
Looking at the trends, the average annual growth has slowed over the years. For instance, post-2014's significant 10.21% increase, 2018 saw a modest rise of 2.05%, and 2019 even recorded a slight decline. The market bounced back with varying degrees of growth, such as a 4.39% increase in 2020. The last two years showed gradual growth, with 2.52% and 2.76% increases in 2022 and 2023.
Future forecasts anticipate the market to continue growing, with the volume reaching 37.4 units by 2028. However, the growth rate will likely stabilize, exhibiting a forecasted 5-year CAGR of 1.75%. Key future trends to watch include the impact of healthcare policies, advancements in generic drug formulations, and market penetration of biosimilars.
